The 'proven scaling CEO' story precedes a financing/dilution within 8 weeks — and coverage will retroactively frame the hire as runway management.

When a psychedelic biotech announces a well-known executive joining as CEO, the real purpose is often to generate positive press before raising money by selling new shares. Once the fundraise happens, journalists and analysts will look back and describe the CEO hire as a way to 'manage the cash runway' — meaning buy time and confidence while the company scrambled for money. The announcement was the setup; the fundraise is the actual news.

This is a placed-narrative pattern. Hire a big-name CEO, generate buzz, then raise into the story. I've seen the playbook. The readout is the actual risk event.